We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lilly Collaborating With Alkermes on Inhalable Osteoporosis Treatments
Lilly Collaborating With Alkermes on Inhalable Osteoporosis Treatments
January 9, 2006
Eli Lilly and Alkermes have signed a joint agreement to develop and commercialize inhaled formulations of parathyroid hormone (PTH), an osteoporosis treatment.